Groh, Matthieu

Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management

Groh, M., Pagnoux, C., Baldini, C., Bel, E., Bottero, P., Cottin, V., Dalhoff, K., Dunogué, B., Gross, W., Holle, J., et al. (2015) · European Journal of Internal Medicine

Vasculitis and related conditionsEosinophilic Disorders and Syndromes

Cited by 476

Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

Cottin, V., Bel, E., Bottero, P., Dalhoff, K., Humbert, M., Lazor, R., Sinico, R. A., Sivasothy, P., Wechsler, M. E., Groh, M., et al. (2017) · Autoimmunity Reviews

Vasculitis and related conditionsOtitis Media and Relapsing Polychondritis

Cited by 175

Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database

Scanvion, Q., Béné, J., Gautier, S., Grandvuillemin, A., Le Beller, C., Chenaf, C., Etienne, N., Brousseau, S., Cortot, A. B., Mortier, L., et al. (2020) · OncoImmunology

Eosinophilic Disorders and SyndromesCancer Immunotherapy and Biomarkers

Cited by 59

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors

Roger, A., Groh, M., Lorillon, G., Le Pendu, C., Maillet, J., Arangalage, D., Tazi, A., Lebbe, C., Baroudjian, B., & Delyon, J. (2019) · Annals of the Rheumatic Diseases

Vasculitis and related conditionsCancer Immunotherapy and Biomarkers

Cited by 39